Suchergebnisse - "Engelhardt, Monika"

PubPharm (430)

91

Kinetics of Renal Function during Induction in Newly Diagnosed Multiple Myeloma : Results of Two Prospective Studies by the German Myeloma Study Group DSMM

enthalten in: Cancers | 2021

von Bachmann, F. | Schreder, M. | Engelhardt, M. | +30

92

Treatment of relapsed and refractory multiple myeloma : recommendations from the International Myeloma Working Group

enthalten in: The Lancet. Oncology | 2021

von Moreau, P. | Kumar, S. | San Miguel, J. | +67

93

Treatment of therapy-related acute myeloid leukemia and underlying multiple myeloma with decitabine/venetoclax and daratumumab

enthalten in: Annals of hematology | 2021

von Shoumariyeh, K. | Jung, J. | Rassner, M. | +8

94

Treatment of therapy-related acute myeloid leukemia and underlying multiple myeloma with decitabine/venetoclax and daratumumab

enthalten in: Annals of hematology | 2021

von Shoumariyeh, K. | Jung, J. | Rassner, M. | +8

95

Treatment of therapy-related acute myeloid leukemia and underlying multiple myeloma with decitabine/venetoclax and daratumumab

enthalten in: Annals of hematology | 2021

von Shoumariyeh, K. | Jung, J. | Rassner, M. | +8

96

Validation of the revised myeloma comorbidity index and other comorbidity scores in a multicenter German study group multiple myeloma trial

enthalten in: Haematologica | 2021

von Dold, S. | Möller, M. | Ihorst, G. | +8

97

Multidisciplinary tumor boards and their analyses : the yin and yang of outcome measures

enthalten in: BMC cancer | 2021

von Engelhardt, M. | Ihorst, G. | Schumacher, M. | +8

98

Multidisciplinary tumor boards and their analyses: the yin and yang of outcome measures

enthalten in: BMC cancer | 2021

von Engelhardt, M. | Ihorst, G. | Schumacher, M. | +8

99

Real-World Evaluation of Health-Related Quality of Life in Patients With Multiple Myeloma From Germany

enthalten in: Clinical lymphoma, myeloma & leukemia | 2021

von Engelhardt, M. | Ihorst, G. | Singh, M. | +4

100

Healthcare resource utilization and costs among patients with relapsed and/or refractory multiple myeloma treated with proteasome inhibitors in real-world clinical practice in Germany

enthalten in: Journal of medical economics | 2021

von Steinmetz, T. | Singh, M. | Lebioda, A. | +5